PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19: Coronavirus - COVID-19 - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
October 27, 2021 Newswires
Share
Share
Post
Email

PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19: Coronavirus – COVID-19

Vaccine Daily

2021 OCT 27 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Daily -- Staff editors report on the newly launched clinical trial, NCT05075941, which has the following summary description: “The main objective of the study is to assess the level of vaccination coverage (VC) against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing. The secondary objectives are : - to compare the estimated level of vaccination coverage in the different sites and strata (emergency shelters/hotels, camps, workers’ hostels, on the street) with the estimated level in the general population of the same territory obtained from the French Health Insurance data (SIVAC). - identify the obstacles and leverage of vaccination (i.e. mobile team) according to living conditions and habitat (socio-demographic factors, personal health history, vaccine adherence, local health policies, etc.).”

As a matter of record, on October 14, 2021, NewsRx staff editors report that the available information provided by Epicentre on this trial include:

Tracking Information

Trial Identifier NCT05075941
First Submitted Date October 7, 2021
First Posted Date October 13, 2021
Results First Submitted Date Not Provided
Results First Posted Date Not Provided
Last Update Submitted Date October 7, 2021
Last Update Posted Date October 13, 2021
Primary Completion Date December 31, 2021
Start Date November 2021
Current Primary Outcome Measures •Vaccination coverage among COVID-19 [ Time Frame: one month ] -- Assess the proportion of people declaring to have received at least one dose of vaccination against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing
•Identify the most appropriate conditions for the use of vaccination against COVID-19 [ Time Frame: one month ] -- Promote interventions to encourage the use of COVID-19 vaccination
Current Secondary Outcome Measures Not Provided
Other Outcome Measures Not Provided
Change History Complete list of historical revisions of study NCT05075941

Descriptive Information

Brief Title Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations
Official Title PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19
Brief Summary The main objective of the study is to assess the level of vaccination coverage (VC) against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing. The secondary objectives are : - to compare the estimated level of vaccination coverage in the different sites and strata (emergency shelters/hotels, camps, workers’ hostels, on the street) with the estimated level in the general population of the same territory obtained from the French Health Insurance data (SIVAC). - identify the obstacles and leverage of vaccination (i.e. mobile team) according to living conditions and habitat (socio-demographic factors, personal health history, vaccine adherence, local health policies, etc.).
Detailed Description Not Provided
Study Type Observational
Study Phase Not Provided
Study Design Observational Model: Other
Time Perspective: Cross-Sectional
Condition COVID-19
Intervention •Other: Vaccination coverage
proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population
Study Arms •Covid Homeless and migrants Marseille
Interventions:
⚬Other: Vaccination coverage
•Shelters Paris/93
Interventions:
⚬Other: Vaccination coverage
•Street/Camps Paris/93
Interventions:
⚬Other: Vaccination coverage
•Workers’ hostels Paris/93
Interventions:
⚬Other: Vaccination coverage
•travelling community IDF(77/93/95)
Interventions:
⚬Other: Vaccination coverage

Recruitment Information

Recruitment Status Not yet recruiting
Estimated Enrollment 3470
Estimated Completion Date February 2022
Primary Completion Date December 31, 2021 (Final data collection date for primary outcome measure)
Eligibility Inclusion Criteria:
•Adult (18 years and older)
•People considered as homeless (homeless, living in a camp or squat) or
•Living in adapted housing (migrant workers’ hostel) or
•Housed in residences of the National System or
•Housed in a social residence such as a 115 hotel or a social housing centre
•Freely and voluntarily consenting to participate Exclusion Criteria:
•Refusal to participate in the study (non-consent).
•Language barrier with no in-person or telephone translation available.
•Impossibility to give free and informed consent (comprehension barrier, cognitive and/or psychiatric and/or addictive disorders, external pressure from family and friends, persons under guardianship, etc.).
Sex/Gender Sexes Eligible for Study: All
Ages 18 years and older
Accepts Healthy Volunteers Not Provided
Contacts Primary contact: Thomas ROEDERER, +33 1 40 21 55 55, [email protected]
Backup contact: Jessica SAYYAD, +33 1 40 21 55 55, [email protected]
Listed Location Countries Not Provided
Removed Location Countries

Administrative Information

NCT Number NCT05075941
Other Study ID Numbers 2021-A01960-41
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
Plan to Share Data Yes
Plan to Share Data (IPD) Description The results will be presented in a report to the Ministry of Health, the Haute Autorite de Sante and the various partners. The main findings of this study could potentially be compared with the findings of other ongoing studies, once they are completed. An abstract of the findings will be submitted for presentation at a scientific conference, and at least one manuscript will be submitted for publication in a peer-reviewed scientific journal.
Responsible Party Epicentre
Collaborators ⚬SANTE PUBLIQUE FRANCE
⚬Medecins Sans Frontieres, Netherlands
⚬Medecins du Monde
⚬CROIX ROUGE FRANCAISE
⚬OBSERVATOIRE DU SAMU SOCIAL
⚬INTERLOGEMENT 93
⚬Agence Regionale de Sante d’Ile de France
Investigators Principal Investigator: Elisabeth POULET, MD, Epicentre
Information Provided By Epicentre
Verification Date October 2021

(Our reports deliver fact-based news of research and discoveries from around the world.)

Older

Riverside Health System enters health insurance business with launch of Medicare supplement plan [Daily Press]

Newer

Fort Worth Health Insurance Sees Massive Overhaul In Seven Ways With New Spending Bill

Advisor News

  • IRS CEO FRANK J. BISIGNANO VISITS OHIO TO TOUT WORKING FAMILIES TAX CUTS PROVISIONS ON NO TAX ON CAR LOAN INTEREST, NO TAX ON OVERTIME, ENHANCED DEDUCTION FOR SENIOR CITIZENS
  • The hidden flaw in insurance AI adoption for advisors and carriers
  • Rising healthcare costs impact 401(k) accounts
  • What advisors think about pooled employer plans, alternative investments
  • AI, stablecoins and private market expansion may reshape financial services by 2030
More Advisor News

Annuity News

  • MetLife Inc. (NYSE: MET) Climbs to New 52-Week High
  • The Standard and Pacific Guardian Life Announce Entry into Agreement to Transition Individual Annuities Business
  • AuguStar Retirement launches StarStream Variable Annuity
  • Prismic Life Announces Completion of Oversubscribed Capital Raise
  • Guaranteed income streams help preserve assets later in retirement
More Annuity News

Health/Employee Benefits News

  • Reed: Can these assets be saved?
  • PacificSource to end Montana operations
  • PacificSource to end Montana insurance operations
  • Reduced health insurance payments for hospital births had a bigger impact on sterilization rates than correcting an injustice
  • Ashley Mann:
More Health/Employee Benefits News

Life Insurance News

  • Investigators say C.R. man's life insurance claims for 3 children were fraudulent
  • Shocking death of Kyle Busch renews debate over IUL plan
  • WoodmenLife launches final expense life insurance offering
  • The Standard and Pacific Guardian Life Announce Entry into Agreement to Transition Individual Annuities Business
  • Symetra Wins 2026 Shorty Award for ‘Plan Well, Play Well’ Social Media Campaign with Sue Bird
More Life Insurance News

- Presented By -

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Why Blend in When You Can Make a Splash?
Pacific Life’s registered index-linked annuity offers what many love about RILAs—plus more!

Life moves fast. Your BGA should, too.
Stay ahead with Modern Life's AI-powered tech and expert support.

Bring a Real FIA Case. Leave Ready to Close.
A practical working session for agents who want a clearer, repeatable sales process.

Discipline Over Headline Rates
Discover a disciplined strategy built for consistency, transparency, and long-term value.

You Could Be Losing Up to 20% of Your Commissions
GreenWave helps you find, fix, and prevent commission errors.

Press Releases

  • JP Insurance Group Launches Commercial Property & Casualty Division; Appoints Joe Webster as Managing Director
  • Sequent Planning Recognized on USA TODAY’s Best Financial Advisory Firms 2026 List
  • Highland Capital Brokerage Acquires Premier Financial, Inc.
  • ePIC Services Company Joins wealth.com on Featured Panel at PEAK Brokerage Services’ SPARK! Event, Signaling a Shift in How Advisors Deliver Estate and Legacy Planning
  • Hexure Offers Real-Time Case Status Visibility and Enhanced Post-Issue Servicing in FireLight Through Expanded DTCC Partnership
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.
Insurance News | InsuranceNewsNet